15. 封入体筋炎 Inclusion body myositis Clinical trials / Disease details


臨床試験数 : 42 薬物数 : 60 - (DrugBank : 16) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 123

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04421677
(ClinicalTrials.gov)
August 20, 202018/5/2020Safety and Tolerability of Phenylbutyrate in Inclusion Body MyositisSafety and Tolerability of Phenylbutyrate in Inclusion Body MyositisInclusion Body Myositis;Sporadic Inclusion Body MyositisDrug: Phenylbutyrate Oral TabletUniversity of Kansas Medical CenterNULLActive, not recruiting18 YearsN/AAll10Phase 1United States